drugset / Trial / NCT02151591

New Approaches to Smoking Cessation in Heavy Drinkers

NCT02151591

RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to develop and test an integrated cognitive-behavioral intervention for smoking and alcohol among heavy drinking smokers. The current pre-pilot phase will be used to refine this protocol for the subsequent randomized, controlled pilot phase. The current study phase has two parts: 1) an intake session and brief physical; 2) a 12-week treatment phase in which participants receive varenicline (Chantix) and weekly, personalized counseling.

Timeline

Start
2017-03-01
Primary completion
2018-06-01
Completion
2018-08-01

Drugs

EvaluationDrugModalityDoseRoute
Background Varenicline Small molecule 1 mg